Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players√Ę‚ā¨‚ĄĘ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Request Free Sample
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.
Speak to Analyst

Avian Influenza Vaccine Market Research Report Information, by Strain (H5, H7, H9), Application (Chicken, Turkey, Goose & Duck) and Region (APAC & Middle East, Europe, Americas, Africa) - Forecast till 2032


ID: MRFR/HC/7297-CR | 101 Pages | Author: Rahul Gotadki| February 2020

Avian Influenza Vaccine Market Overview


The Avian Influenza Vaccine market is anticipated to reach USD 1.18 Billion 2032 at a CAGR 7.5% during the forecast period 2023-2032.


  Avian influenza, also known as bird flu, is a viral infection that spreads from bird to bird and can infect other animals or humans also. There are different strains of avian influenza, causing the infection, but H5V1 is the most common virus strain affecting poultry animals.


Market Dynamics


The increasing strategic agreements are expected to drive market growth during the study period. For instance, in February 2018, the NC State College of Veterinary Medicine and Ceva Santé Animale, an animal health company, based in France, collaborated on a distance learning project providing certification in poultry health management for veterinarians in Latin America. Moreover, the increasing public & private initiatives by the government as well as non-government organizations for research & development are also anticipated to drive the market growth.


Avian Influenza Vaccine Market, by Strain, 2018 & 2025 (USD Million) Avian Influenza Vaccine Market


Source: MRFR Analysis


Segmentation


The Avian Influenza Vaccine Market has been segmented by strain and application. The market, based on strain, has been bifurcated into H5, H7, and H9. Based on application, the avian influenza vaccine market has been chicken, turkey, and goose & duck.


Africa Avian Influenza Vaccine Market Share, 2018 (%) Avian Influenza Vaccine Market


Source: MRFR Analysis


Regional Analysis


The Avian Influenza Vaccine Market, based on region, has been divided into the APAC & Middle East, Europe, Americas, and Africa.


The APAC & Middle East is likely to dominate the avian influenza vaccine market. This can be attributed to the increasing production of poultry birds and the rise in avian influenza outbreaks in the region. According to a recent report from the Foreign Agricultural Service/USDA, China recorded 13,800 thousand metric tons of chicken meat production in 2019. Furthermore, various government initiatives for rapid and effective response efforts to emergent zoonotic influenza viruses are also expected to drive market growth.


The European market for the avian influenza vaccine is estimated to be the second-largest during the review period. The growing dependence on poultry as the key source of protein in the diet in this region is expected to boost the growth of the regional market. According to the European Commission, the European Union (EU) produced 15.2 million tons of poultry meat in 2018. Additionally, increasing the production of veterinary products and improved animal husbandry practices in Germany and Poland are further fueling market growth.


Americas is estimated to demonstrate significant market growth owing to the growing meat & poultry industry, the increasing expenditure on animal health, and the presence of a large number of veterinary hospitals in the region. According to the North American Meat Institute, the US exported 3.7 million metric tons (MT) of poultry and poultry variety meats in 2017. The value was estimated at USD 4.5 billion. Moreover, growing government support for creating awareness on avian influenza viruses and improving efficiency for the avian influenza vaccine is also positively affecting the market growth.


Key Players


The Prominent Players in the Avian Influenza Vaccine Market are Boehringer Ingelheim International GmbH (Germany), Guangdong Wenshi Dahuanong Biotechnology Co., Ltd (China), Ceva (US), Yebio Bioengineering Co., Ltd (China), Zoetis (US), FATRO S.P.A. (Italy), CAVAC (South Korea), Tianjin Ringpu Bio-Technology Co., Ltd (China), PT Japfa Comfeed Indonesia Tbk (Indonesia), Chengdu Tech-bank Biological Products Co., Ltd (China), Merck Animal Health (US), Medion (Indonesia), Avimex Animal Health (Mexico), JOVAC (Jordan), and QYH BIOTECH COMPANY LIMITED (China). Some of the key strategies followed by players operating in the avian influenza vaccine market were collaborations, acquisition, product approval & launch, and expansion.




  • In October 2019, Ceva and ProBioGen AG signed an exclusive license agreement for the manufacture of vectorized poultry vaccines using ProBioGen‚Äôs proprietary AGE1.CR technology.




  • In October 2018, Boehringer Ingelheim announced the opening of its biological research and development site in France. It invested USD 80.45 million (EUR 70 million) for maintaining its leading position in veterinary vaccines.




  • In August 2017, Merck Animal Health announced the plans to purchase a new manufacturing facility in Austria. With this purchase, the company was intended to expand its global vaccine manufacturing capacity.




  • In March 2016, Zoetis announced that the US Department of Agriculture (USDA) granted the company a conditional license for Avian Influenza Vaccine, H5N1 Subtype, and Killed Virus.


Market Segmentation


Avian Influenza Vaccine Market, by Strain



  • H5

  • H7

  • H9


Avian Influenza Vaccine Market, by Application



  • Chicken

  • Turkey

  • Duck & Goose


Avian Influenza Vaccine Market, by Region




  • APAC & Middle East

    • China

    • Philippines

    • Vietnam

    • India

    • Bangladesh

    • Cambodia

    • Indonesia

    • Iran

    • Thailand

    • Pakistan

    • Rest of APAC & Middle East




  • Europe

    • Germany

    • Bulgaria

    • Poland

    • Hungary

    • Ukraine

    • Czech Republic

    • Rest of Europe




  • Americas

    • US

    • Brazil

    • Mexico

    • Argentina

    • Columbia

    • Rest of the Americas




  • Africa

    • South Africa

    • Nigeria

    • Ghana

    • Cameroon

    • Rest of Africa




Available Additional Customizations



  • Challenges in the Avian Influenza Vaccine Market

  • Investment Opportunities in the Avian Influenza Vaccine Market


Intended Audience



  • Pharmaceutical companies

  • Biotechnology companies

  • Contract research organizations

  • Research & development organizations

  • Academic institutes

Report Attribute/Metric Details
  Market Size ·USD 1.18 Billion
  CAGR   7.5%
  Base Year   2019
  Forecast Period   2023-2032
  Historical Data   2020
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Strain, Application
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Boehringer Ingelheim International GmbH (Germany), Guangdong Wenshi Dahuanong Biotechnology Co., Ltd (China), Ceva (US), Yebio Bioengineering Co., Ltd (China), Zoetis (US), FATRO S.P.A. (Italy), CAVAC (South Korea), Tianjin Ringpu Bio-Technology Co., Ltd (China), PT Japfa Comfeed Indonesia Tbk (Indonesia), Chengdu Tech-bank Biological Products Co., Ltd (China), Merck Animal Health (US), Medion (Indonesia), Avimex Animal Health (Mexico), JOVAC (Jordan), and QYH BIOTECH COMPANY LIMITED (China).
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers ·  Increasing strategic agreements·  Increasing public & private initiatives for research & development
 

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Request Free Sample
Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.
Ask for Customization